Antibiotic resistance is a well-known consequence of antibiotic overuse, but the failure of antibiotics in some cases has prompted researchers to explore additional factors. In a recent study, UNC School of Medicine and Duke School of Medicine researchers uncovered a significant link between the evolution of persister cells in E. coli and antibiotic treatment failure, providing a deeper understanding beyond classic antibiotic resistance. Their findings were published in the Proceedings of the National Academy of Sciences (PNAS).

Persister cells, sub-populations of bacteria capable of surviving lethal antibiotic doses for extended periods, have been the subject of extensive research, but evidence connecting them to poor patient outcomes has been limited. The team's study, using patient data, clinical isolates, and animal models, demonstrated that E. coli can evolve in patients to produce increased persister cells, resulting in enhanced survival against antibiotics.

While antibiotic resistance is a global concern, the study suggests that antibiotic failure is a multifaceted issue, particularly when classic resistance is not the sole cause. The team's research utilized clinical E. coli bacteremia isolates, revealing the evolution of high-persister mutants in patients. These mutants exhibited a 100-fold increase in persisters when exposed to the antibiotic used for treatment, showcasing the role of persister cells in treatment failure.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

“Our research strongly suggests that persister formation is an important metric to consider when treating patients with antibiotics,” explained senior author Brian Conlon, who added that researchers should develop techniques to identify mutants that are likely to respond poorly to antibiotics because such information would influence treatment choices or duration of treatment.